LeukoSite
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
LeukoSite - overview
Established
1992
Location
Cambridge, MA, US
Primary Industry
Pharmaceuticals
About
LeukoSite, Inc. is based in US and developes new drugs designed to block disease-promoting actions of white blood cells.
Current Investors
Perseus, Goldman Sachs Asset Management
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceuticals
Verticals
Manufacturing
Company Stage
Acquired
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.